PNC Financial Services Group Inc. increased its stake in Exponent Inc. (NASDAQ:EXPO) by 85.8% during the third quarter, according to its most recent filing with the SEC. The firm owned 480,132 shares of the company’s stock after buying an additional 221,715 shares during the period. PNC Financial Services Group Inc. owned 1.81% of Exponent worth $24,515,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Bank of New York Mellon Corp boosted its position in shares of Exponent by 2.8% in the third quarter. Bank of New York Mellon Corp now owns 340,488 shares of the company’s stock valued at $17,385,000 after buying an additional 9,395 shares during the last quarter. Victory Capital Management Inc. boosted its position in shares of Exponent by 3.1% in the third quarter. Victory Capital Management Inc. now owns 2,518 shares of the company’s stock valued at $129,000 after buying an additional 76 shares during the last quarter. TD Asset Management Inc. boosted its position in shares of Exponent by 31.5% in the third quarter. TD Asset Management Inc. now owns 11,700 shares of the company’s stock valued at $597,000 after buying an additional 2,800 shares during the last quarter. Aperio Group LLC boosted its position in shares of Exponent by 4.7% in the third quarter. Aperio Group LLC now owns 8,659 shares of the company’s stock valued at $442,000 after buying an additional 387 shares during the last quarter. Finally, BB&T Corp boosted its position in shares of Exponent by 2.0% in the third quarter. BB&T Corp now owns 4,767 shares of the company’s stock valued at $243,000 after buying an additional 92 shares during the last quarter. 93.87% of the stock is currently owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Shares of Exponent Inc. (NASDAQ:EXPO) traded down 0.16% during trading on Tuesday, reaching $62.85. 21,246 shares of the company’s stock were exchanged. The company has a market capitalization of $1.61 billion, a PE ratio of 36.33 and a beta of 0.65. The company has a 50 day moving average price of $56.88 and a 200-day moving average price of $53.75. Exponent Inc. has a 52-week low of $44.82 and a 52-week high of $63.55.

Exponent (NASDAQ:EXPO) last announced its earnings results on Wednesday, October 19th. The company reported $0.42 EPS for the quarter, topping the consensus estimate of $0.34 by $0.08. The firm had revenue of $77.60 million for the quarter, compared to the consensus estimate of $74.46 million. Exponent had a net margin of 15.06% and a return on equity of 15.72%. The business’s quarterly revenue was down .4% on a year-over-year basis. During the same quarter last year, the firm posted $0.43 EPS. On average, equities analysts forecast that Exponent Inc. will post $1.70 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 23rd. Stockholders of record on Friday, December 2nd will be issued a dividend of $0.18 per share. The ex-dividend date is Wednesday, November 30th. This represents a $0.72 annualized dividend and a dividend yield of 1.15%. Exponent’s payout ratio is 41.86%.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another website, it was illegally stolen and republished in violation of international trademark and copyright legislation. The correct version of this report can be viewed at https://www.thecerbatgem.com/2016/11/29/exponent-inc-expo-shares-bought-by-pnc-financial-services-group-inc.html.

A number of equities analysts have issued reports on EXPO shares. Zacks Investment Research raised shares of Exponent from a “hold” rating to a “strong-buy” rating and set a $66.00 target price on the stock in a report on Monday, October 24th. Cantor Fitzgerald set a $57.00 target price on shares of Exponent and gave the stock a “buy” rating in a report on Thursday, October 20th.

In other news, insider Harri Kytomaa sold 5,500 shares of the business’s stock in a transaction dated Monday, November 14th. The shares were sold at an average price of $61.91, for a total transaction of $340,505.00. Following the transaction, the insider now owns 11,371 shares in the company, valued at approximately $703,978.61. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Michael R. Gaulke sold 8,750 shares of the business’s stock in a transaction dated Thursday, October 20th. The stock was sold at an average price of $55.14, for a total transaction of $482,475.00. The disclosure for this sale can be found here. Insiders own 3.50% of the company’s stock.

About Exponent

Exponent, Inc, along with its subsidiaries, is a science and engineering consulting company. The Company operates through two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, technology development, thermal sciences and vehicle analysis services.

5 Day Chart for NASDAQ:EXPO

Receive News & Stock Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related stocks with our FREE daily email newsletter.